Cognitive outcomes from the randomised, active-controlled Ketamine for Adult Depression Study (KADS)

- Martin, Donel M., Harvey, Anna J., Hackett, Maree, Mills, Natalie, Sarma, Shanthi, Somogyi, Andrew, Rodgers, Anthony, Loo, Colleen K., Baune, Bernard, Berk, Michael, Carter, Gregory L., Dong, Vanessa, Glozier, Nick, Glue, Paul, Hood, Sean, Hadzi-Pavlovic, Dusan

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial

- Loo, Colleen, Glozier, Nick, Alonzo, Angelo, Dong, Vanessa, Martin, Donel, Nikolin, Stevan, Mitchell, Philip B., Berk, Michael, Carter, Gregory, Hackett, Maree, Leyden, John, Hood, Sean, Barton, David, Somogyi, Andrew A., Lapidus, K, Stratton, E, Gainsford, K, Garg, D, Thornton, NLR, Fourrier, C, Richardson, K, Rozakis, D, Scaria, A, Baune, Bernhard T., Mihalopoulos, C, Chatterton, ML, McDonald, WM, Boyce, P, Holtzheimer, PE, Kozel, FA, Riva-Posse, P, Rodgers, A, Mills, Natalie T., Fitzgerald, Paul, Glue, Paul, Sarma, Shanthi, Galvez-Ortiz, Veronica, Hadzi-Pavlovic, Dusan

Effects of low-dose and very low-dose ketamine among patients with major depression: a systematic review and meta-analysis

- Xu, Ying, Hackett, Maree, Mitchell, Philip B., Rodgers, Anthony, Carter, Gregory, Loo, Colleen, Gálvez, Verònica, Glozier, Nick, Glue, Paul, Lapidus, Kyle, McGirr, Alexander, Somogyi, Andrew A.